Previous studies revealed that a low serum SHBG concentration was positively correlated with a higher risk of polycystic ovary syndrome (PCOS) and PCOS-related metabolic disturbances (7), breast cancer incidence and mortality (8), type 2 diabetes (T2D) (9), and cardiovascular disease risk (10). This evidence concerns the gene SHBG and breast carcinoma.